ChinaFile Recommends

07.17.13

For Global Drug Manufacturers, China Becomes a Perilous Market

Katie Thomas
New York Times
Selling pharmaceuticals and other health care products in China is increasingly fraught with peril. China is accusing GlaxoSmithKline of funnelling payments through travel agents to doctors, hospitals and government officials to bolster...